Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.
LabEx DEVweCAN, Université de Lyon, Lyon, France.
Cancer Res. 2018 Jan 1;78(1):30-35. doi: 10.1158/0008-5472.CAN-17-2476. Epub 2017 Dec 18.
ZEB1 is a prime element of a network of transcription factors that controls epithelial-to-mesenchymal transition (EMT), a reversible embryonic transdifferentiation program that allows partial or complete transition from an epithelial to a mesenchymal state. Aberrant expression of ZEB1 has been reported in a variety of human cancers, where it is generally believed to foster migration, invasion, and metastasis. Over the past few years, and observations have highlighted unsuspected intrinsic oncogenic functions of ZEB1 that impact tumorigenesis from its earliest stages. Located downstream of regulatory processes that integrate microenvironmental signals and directly implicated in feedback loops controlled by miRNAs, ZEB1 appears to be a central switch that determines cell fate. Its expression fosters malignant transformation through the mitigation of critical oncosuppressive pathways and through the conferment of stemness properties. ZEB1 is also a key determinant of cell plasticity, endowing cells with the capacity to withstand an aberrant mitogenic activity, with a profound impact on the genetic history of tumorigenesis, and to adapt to the multiple constraints encountered over the course of tumor development. .
ZEB1 是转录因子网络的主要成分之一,该网络控制上皮-间充质转化(EMT),这是一种可逆的胚胎转分化程序,允许部分或完全从上皮状态向间充质状态转变。在多种人类癌症中都报道了 ZEB1 的异常表达,通常认为它促进了迁移、侵袭和转移。在过去的几年中,越来越多的观察结果强调了 ZEB1 潜在的内在致癌功能,这些功能影响肿瘤发生的最早阶段。ZEB1 位于整合微环境信号的调节过程的下游,并直接参与 miRNA 控制的反馈回路,它似乎是决定细胞命运的中央开关。它的表达通过减轻关键的肿瘤抑制途径和赋予干性特征来促进恶性转化。ZEB1 也是细胞可塑性的关键决定因素,赋予细胞耐受异常有丝分裂活性的能力,对肿瘤发生的遗传史有深远影响,并适应肿瘤发展过程中遇到的多种限制。